China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

Clinical trial NCT04974138 · RECRUITING

Trial details

NCT number: NCT04974138
Sponsor: Shenzhen Ausa Pharmed Co.,Ltd
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension MTHFR 677 CC or CT Genotype Elevated Plasma Homocysteine (Hcy≥10µmol/L)Insufficient Plasma Folate Levels (<12ng/mL)

Start date: 2024-08-22
Primary completion: 2030-06-30
Enrollment: 32000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.